There was no statistically significant difference in the baseline characteristics of patients and ovarian stimulation between GH treatment and control groups, except for duration of infertility (3.67 ± 2.52 vs. 3.29 ± 2.48; p = 0.030) and the protocol used for ovarian stimulation (p < 0.001). The gene discussed is GH1; the disease is Infertility.